EMA & Biosimilar Update: Trends from marketing authorisation applications, scientific advice procedures and policies – Peter Richardson, EBG Biosimilars 2015, London (PPT)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok